Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

War and public health, experiances from war against Croatia 1991-1995

Autor: Gotovac, Petar, Perić, Darinka, Zlatar, Marijan, Baklaić, Željko, Srbljin, S., Ropac, Darko, Ljubičić, Mate

Croatia was attacked 1991 by Yugoslavia Army Forces. As the risks of viololence and war can be monitored, forecasts made an appropriate preventive actions sholud be taken in proper time.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::2a505259dedc8971386f69747fdf16ea
https://www.bib.irb.hr/361049

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.

Autor: Luining WI; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands. Electronic address: w.i.luining@amsterdamumc.nl., Boevé LMS; Department of Urology, OLVG, Amsterdam, The Netherlands., Hagens MJ; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., de Weijer T; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Ettema RH; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Roeleveld TA; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands; Department Urology, Northwest Clinics, Alkmaar, The Netherlands., Srbljin S; Department of Nuclear Medicine, Zaans Medical Center, Zaandam, The Netherlands., Weltings S; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Zaans Medical Center, Zaandam, The Netherlands., Koppes JCC; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Cysouw MCF; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Apr 30. Date of Electronic Publication: 2024 Apr 30.